Stay updated on Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial
Sign up to get notified when there's something new on the Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial page.

Latest updates to the Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference4%
- Check19 days agoChange DetectedUpdated page to version v3.1.0 with a new contact-like entry (zhouap1825@126.com) and an added numeric identifier; the old version tag v3.0.2 was removed. Overall, the substantive content appears largely unchanged; versioning and contact information are the primary changes.SummaryDifference0.1%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedUpdated the page revision from v3.0.1 to v3.0.2; removed the Back to Top element.SummaryDifference0.3%
- Check41 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.3%
- Check48 days agoChange DetectedThe web page has updated its facility name and location details, including specific drug information for Fruquintinib and sintilimab, while also removing previous location references and an older revision number.SummaryDifference2%
- Check62 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial page.